Definium Therapeutics Inc. Common Shares vs Rio Tinto (ADR) — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.95 (market cap $4.59B), while Rio Tinto (ADR) trades at $94.2 (market cap $150.89B). The key difference: Rio Tinto (ADR) is far larger — about 32.9× Definium Therapeutics Inc. Common Shares's market cap, and Rio Tinto (ADR) pays a 4.98% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Rio Tinto (ADR) for 10 Days on average.
| DFTX | RIO | |
|---|---|---|
Market Cap | $4.59B | $150.89B |
Volume | 2,103,937 | 1,492,444 |
Sector | Health | Basic Materials |
52-Week High | $48.45 | $112.04 |
52-Week Low | $10.68 | $65.44 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $3.55B | $164.24B |
Dividend Yield | — | 4.98% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Rio Tinto is a global mining company that produces metals and minerals including iron ore, aluminium, copper, and lithium. Its operations supply materials used in construction, manufacturing, transportation, and energy systems.
Read more on RIO →